Paul Underwood, MD

Original Contribution

Comparison of Twelve-Month Outcomes After Percutanous Coronary Intervention With Everolimus-Eluting Versus Zotarolimus-Eluting or Sirolimus-Eluting Stents From the PROENCY (PROmus ENdeavor CYpher) Registry

10/01/2012

Jan G.P. Tijssen , PhD;

Paul Underwood , MD;

Christian W. Hamm , MD, PhD, FESC;

Peter Damman , MD;

Mohamed Abdel-Wahab , MD;

Gert Richardt , MD, PhD;

Bernard Chevalier , MD;

Paul Barragan , MD;

Abstract: Objectives. We compared safety and efficacy outcomes of 3 limus-based drug-eluting stents in the ‘all-comers’ PROENCY (PROmus/ENdeavor /CYpher) registry. Background. Limited data are available on head-to-head comparisons of the...

Abstract: Objectives. We...

10/01/2012

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Paul Underwood, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products